This item is authorised by the following title:
Health Insurance Legislation Amendment (Listing of Selpercatinib) Determination 2026 (F2026L01001)
Health Insurance Legislation Amendment (Listing of Futibatinib) Determination 2026 (F2026L00632)
Health Insurance Legislation Amendment (Indexation) Determination 2026 (F2026L00523)
Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment (No. 1) Determination 2025 (F2025L01002)
Health Insurance Legislation Amendment (2025 Measures No.2) Determination 2025 (F2025L00609)
Health Insurance Legislation Amendment (Indexation) Determination 2025 (F2025L00554)
Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment (No. 2) Determination 2024 (F2024L01528)
Health Insurance (Section 3C Co-Dependent Pathology Services) Amendment (No. 1) Determination 2024 (F2024L00555)
Health Insurance (Section 3C Co-Dependent Pathology) Amendment (No. 3) Determination 2023 (F2023L01664)
Health Insurance (Section 3C Co-Dependant Pathology) Amendment (No. 2) Determination 2023 (F2023L01280)
Health Insurance (Section 3C Co-Dependant Pathology Services) Amendment Determination (No.1) 2023 (F2023L01112)
Health Insurance Legislation Amendment (2023 Measures No. 2) Determination 2023 (F2023L00731)
View Explanatory Statement/s
